Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Statistical Methods for Analyzing Epidemiological Data01:25

Statistical Methods for Analyzing Epidemiological Data

Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
Causality in Epidemiology01:21

Causality in Epidemiology

Causality or causation is a fundamental concept in epidemiology, vital for understanding the relationships between various factors and health outcomes. Despite its importance, there's no single, universally accepted definition of causality within the discipline. Drawing from a systematic review, causality in epidemiology encompasses several definitions, including production, necessary and sufficient, sufficient-component, counterfactual, and probabilistic models. Each has its strengths and...
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Uncertainty: Confidence Intervals00:54

Uncertainty: Confidence Intervals

The confidence interval is the range of values around the mean that contains the true mean. It is expressed as a probability percentage. The interpretation of a 95% confidence interval, for instance, is that the statistician is 95% confident that the true mean falls within the interval. The upper and lower limits of this range are known as confidence limits. The confidence limits for the true mean are estimated from the sample's mean, the standard deviation, and the statistical factor 't,' or...
Steps in Outbreak Investigation01:18

Steps in Outbreak Investigation

In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real-time epidemic intelligence in a public health emergency: the 2026 Bundibugyo virus outbreak.

The Lancet. Infectious diseases·2026
Same author

Estimating the Potential Burden of Clinically Significant Hantavirus Cases in Argentina.

The Lancet regional health. Europe·2026
Same author

Non-linear age dynamics of malaria infection and fine-scale environmental exposure in rural Uganda.

BMC medicine·2026
Same author

Shared risk factors for malaria and schistosomiasis co-infection: A systematic review and meta-analysis.

PLoS neglected tropical diseases·2026
Same author

The <i>R</i> = 1 threshold can misclassify epidemic stability.

Communications physics·2026
Same author

Global approaches to infectious disease surveillance and modeling.

Nature medicine·2026

Related Experiment Video

Updated: Jul 9, 2026

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

A decision-theoretic framework for uncertainty quantification in epidemiological modelling.

Nicholas Steyn1, Cathal Mills1,2, Vik Shirvaikar1

  • 1Department of Statistics, University of Oxford.

American Journal of Epidemiology
|July 8, 2026
PubMed
Summary

We introduce a decision-theoretic framework to quantify uncertainty in infectious disease epidemiology. This approach formalizes uncertainty as expected loss, enabling better decision-making and data collection for public health.

Keywords:
Bayesian statisticsdata scienceepidemiologic methodsinfectious disease epidemiologymachine learning (ML)missing datastatistical inferenceuncertainty quantification

Related Experiment Videos

Last Updated: Jul 9, 2026

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

Area of Science:

  • Epidemiology
  • Decision Theory
  • Information Theory

Background:

  • Estimating and communicating uncertainty is crucial in statistical epidemiology for informing public health decisions.
  • Current methods for classifying uncertainty sources are inconsistent, hindering interpretation and targeted data collection.
  • A lack of formalization for uncertainty complicates epidemiological modeling and policy relevance.

Purpose of the Study:

  • To present a first-principles decision-theoretic framework for defining and quantifying uncertainty in epidemiological models.
  • To formally define reducible and irreducible uncertainty based on expected uncertainty reduction from future data.
  • To provide a unified and extended approach for uncertainty quantification in infectious disease epidemiology.

Main Methods:

  • Developed a decision-theoretic framework defining uncertainty as expected loss from incomplete information.
  • Introduced the concept of expected uncertainty reduction to define reducible and irreducible uncertainty.
  • Applied the framework to a SARS-CoV-2 wastewater surveillance case study in Aotearoa New Zealand.

Main Results:

  • Demonstrated a practically relevant definition of uncertainty for epidemiological decision-making.
  • Quantified potential uncertainty reduction through expanded wastewater surveillance.
  • Connected and extended existing ideas from machine learning, information theory, and health economics.

Conclusions:

  • The proposed framework offers a foundation for more reliable and consistent uncertainty quantification in infectious disease epidemiology.
  • This approach enhances the policy relevance of epidemiological estimates by clarifying uncertainty.
  • The framework facilitates a broader application of diverse methods to epidemiological models.